KB Financial Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$27K Buy
397
+53
+15% +$4.5K 0.01% 325
2023
Q2
$32K Buy
+344
New +$26.8K 0.01% 316
2021
Q2
Sell
-162
Closed -$21K 623
2021
Q1
$21K Buy
+162
New +$22.2K 0.01% 358

Other funds holding EXAS

KB Financial Partners's EXAS Position: Q3 2023 in Review

KB Financial Partners increased its Exact Sciences (EXAS) stake by 15% in Q3 2023, buying an estimated $4.5K and bringing the position to 397 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #325.

KB Financial Partners first reported a position in EXAS in Q1 2021 and has held it in 3 quarters since. The position peaked at $32K in Q2 2023. 623 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • KB Financial Partners held 397 shares of Exact Sciences worth $27K as of Q3 2023.
  • KB Financial Partners bought 53 Exact Sciences shares in Q3 2023, an estimated $4.5K.
  • Exact Sciences made up 0.01% of KB Financial Partners's portfolio in Q3 2023, its #325 holding.
  • KB Financial Partners first reported a position in Exact Sciences in Q1 2021 and has held it in 3 quarters since.
  • KB Financial Partners's Exact Sciences position peaked at $32K in Q2 2023.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.